Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 427 entries
View as:

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02309177 Org: User:
Start: 01/12/15 End: 09/12/18 Due: 09/12/19

A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT03324503 Org: User:
Start: 12/08/17 End: 11/15/19 Due: 11/15/20

Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study

Phase: N/A Priority: Normal
NCT ID: NCT02049528 Org: User:
Start: 01/16/14 End: 02/08/14 Due: 02/08/15

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03464097 Org: User:
Start: 06/27/18 End: 10/03/24 Due: 10/03/25

Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00249002 Org: User:
Start: 11/01/05 End: 11/01/07 Due: 11/01/08

A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT02859324 Org: User:
Start: 09/20/16 End: 03/27/20 Due: 03/27/21

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04855136 Org: User:
Start: 06/01/21 End: 04/25/25 Due: 04/25/26

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02531113 Org: User:
Start: 10/09/15 End: 11/28/19 Due: 11/28/20

A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care

Phase: N/A Priority: Normal
NCT ID: NCT00071799 Org: User:
Start: 11/01/03 End: 07/01/07 Due: 07/01/08

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03484702 Org: User:
Start: 06/05/18 End: 12/15/23 Due: 12/15/24

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT02151149 Org: User:
Start: 06/09/14 End: 07/14/17 Due: 07/14/18

Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

Phase: N/A Priority: Normal
NCT ID: NCT01947309 Org: User:
Start: 11/30/13 End: 09/30/16 Due: 09/30/17

PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02387866 Org: User:
Start: 03/02/15 End: 07/27/15 Due: 07/27/16

A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02576717 Org: User:
Start: 10/16/15 End: 01/05/23 Due: 01/05/24

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05065541 Org: User:
Start: 09/24/21 End: 01/29/24 Due: 01/29/25

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01324947 Org: User:
Start: 03/01/11 End: 07/31/14 Due: 07/31/15

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Phase: N/A Priority: Normal
NCT ID: NCT04618081 Org: User:
Start: 12/17/20 End: 03/27/25 Due: 03/27/26

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01724177 Org: User:
Start: 11/12/12 End: 03/21/17 Due: 03/21/18

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00394082 Org: User:
Start: 06/01/06 End: 02/01/11 Due: 02/01/12

Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06417229 Org: User:
Start: 05/28/24 End: 02/19/25 Due: 02/19/26

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03742921 Org: User:
Start: 02/04/19 End: 10/31/23 Due: 10/31/24

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01583283 Org: User:
Start: 07/12/12 End: 03/24/21 Due: 03/24/22

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

Phase: N/A Priority: Normal
NCT ID: NCT05175352 Org: User:
Start: 06/07/22 End: 10/11/24 Due: 10/11/25

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00988208 Org: User:
Start: 11/11/09 End: 11/28/16 Due: 11/28/17

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

Phase: N/A Priority: Normal
NCT ID: NCT03435341 Org: User:
Start: 02/28/18 End: 04/30/20 Due: 04/30/21